Precigen, Inc.

PGEN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$6.61+5.42%

2026-08-03

Financials

Valuation Metrics

Precigen, Inc.'s Market Cap is $2.36B. At end of 2025 it was $1.24B. Ranked #1964 of 3,111 in US market (top 63%), #740 of 1,445 on NASDAQ (top 51%), #125 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 46%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.36B	US#1,964/3,111 Sec#125/269
Revenue	$32M	US#2,899/3,111 Sec#169/269
Net Income	$-204M	US—/3,111 Sec—/269
Total Assets	$139M	US#3,023/3,111 Sec#259/269
Net Assets	$20M	US#2,983/3,111 Sec#254/269
Value
P/B	116.46x	US#2,967/3,111 Sec#260/269
P/S	74.59x	US#2,902/3,111 Sec#175/269
FCF Yield	-4.99%	US—/3,111 Sec—/269
Profitability
Op. Margin	-297.21%	US#2,885/3,111 Sec#152/269
Revenue Growth	1633.93%	US#21/3,111 Sec#10/269
Financial Health
Debt Ratio	585.09%	US#2,446/3,111 Sec#238/269
Total Debt	$98M	US#2,424/3,111 Sec#119/269
FCF	$-118M	US#2,625/3,111 Sec#165/269
Cash	$7M	US#2,986/3,111 Sec#270/269
Current Ratio	4.82x	US#489/3,111 Sec#148/269
Performance
1Y Return	295.81%	US#56/3,111 Sec#21/269
1M Return	17.20%	US#163/3,111 Sec#9/269
From 52W High	-1.34%	US#9/3,111 Sec#2/269
1Y MDD	-40.50%	US#1,968/3,111 Sec#147/269
Trading
Volume	7,363,037 shares	US#307/3,111 Sec#19/269
Trading Value	$48M	US#1,587/3,111 Sec#104/269
Per Share
EPS	$-0.77	US—/3,111 Sec—/269
BPS	$0.14	US#2,717/3,111 Sec#230/269